E
Telo Genomics Corp. TELO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 23.97% 10.67% 4.86% -11.16% -22.36%
Total Depreciation and Amortization -32.89% -7.94% 18.22% 18.75% -0.33%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -125.36% -89.87% -65.28% -7.35% -3.32%
Change in Net Operating Assets 215.26% 472.32% 57,700.00% 239.94% 385.85%
Cash from Operations 28.66% 20.34% 7.32% -7.64% -20.52%
Capital Expenditure 92.80% 94.20% 92.69% 95.79% 51.04%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 92.80% 94.20% 92.69% 95.79% 51.04%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -200.00% -200.00% -200.00% -- --
Issuance of Common Stock 12.77% -77.54% -77.54% 4,623.17% 4,623.17%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -23.16% 81.70% 80.48% -- --
Cash from Financing 7.40% -78.40% -78.50% 4,269.00% 4,306.79%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 880.76% -1,092.25% -7,504.92% 98.90% 94.96%
Weiss Ratings